about
Idiopathic Inflammatory Myopathies: Clinical Approach and ManagementClinical Usefulness of Autoantibodies in Idiopathic Inflammatory MyositisThe NuRD architectureIdiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.Immunotherapies for Immune-Mediated Myopathies: A Current PerspectiveClinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts.Immune and myodegenerative pathomechanisms in inclusion body myositisMost patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.Coherent somatic mutation in autoimmune disease.Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle.Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis.Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies.Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory MyopathiesMevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models.Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease.PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weaknessAutoantibodies in polymyositis and dermatomyositis.Diagnosis, pathogenesis and treatment of myositis: recent advances.Muscle disorders: the latest investigations.Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies.Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.An overview of muscle diseases presenting in adulthood.TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia.High-resolution manometry in patients with idiopathic inflammatory myopathy: Elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset.Personalized medicine in rheumatology: the paradigm of serum autoantibodies.Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.[Dermatomyositis-update].Use of rituximab in histologically confirmed idiopathic inflammatory myositis: a case series.Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment.2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody.Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.Characteristics and predictors of malignancy in dermatomyositis: Analysis of 239 patients from northern China
P2860
Q26744705-33E14704-9460-4A28-AB16-636843076C8CQ26862492-569E92EC-97D8-4DEB-B001-1C25536F8CECQ26865710-6FF94599-F037-4533-83B3-7083E26B2525Q30252086-AD5E79A6-AD3A-433F-8F90-AE21C03E42D0Q30699742-20648168-FBAF-4383-86EB-A0BC1693C157Q33670102-748F6A06-AA91-4789-A013-45E245B5A895Q33753870-F4C1D88B-2BA4-4A85-B4C9-E65E8BC55484Q33814323-B5173D09-08B7-46AA-A8B4-EDA96480744CQ33837769-8AE4C905-2C8C-4830-B383-3C400805DA3BQ34490287-298A8D03-3EED-489F-B53E-BC5821DF3DF1Q34654243-9FF2152F-4041-435C-B7B2-D1D80E1D0A42Q34791339-A8631572-DDD6-411B-995B-D63E0FDBB29CQ35112489-20E2F803-BF69-4568-92FF-CA3A4E29DA58Q35151003-55F07A81-EBD8-43B8-AA64-3AFB2E1BDB13Q35153832-56671DA5-DEB7-4D53-901E-DB7B354F4B4FQ35824298-35956DCE-1DDA-432B-8A29-F115B27D61FCQ36172482-186524B0-6C78-46DF-AFC3-ABE40616637EQ36364785-64195E1F-0710-446F-9A19-E77E39F79218Q36788809-EC7AB757-F9E0-4BA1-AAF7-B98737B44666Q36926351-16BE71C8-C1D2-4891-A85C-ECA318055C16Q38099556-F2160E86-2C91-461F-B745-11974ADF6429Q38131849-4497798F-99F8-4E37-8BF3-D246CCB39A4CQ38134153-6D5AF412-0592-44B4-8CB4-8D025C9EBF67Q38221095-AC570D40-BCED-4CA0-8A4B-366FDE1AD3DAQ38244567-02F5948D-C970-479A-B70E-8B05E4244E8CQ38281749-6D821E0D-898B-4B2E-AF97-CA4F38D47506Q38534871-49D6C32D-5D86-4F6A-9597-6FF14283F8A2Q38604929-670180AC-CE6C-4478-A4ED-30F61E0C3DD3Q38654184-89EA63E6-07B5-4FF1-B8D4-FE45DC0BBFB2Q39116064-07479742-1639-4F5F-B97A-CBFCCA9C56A0Q39432157-79F794F6-E737-4933-A543-3C15547D0490Q39824090-C6AC5859-AE29-4293-9584-BF3A96F55470Q41085880-56B58BA2-B98F-4550-A0EE-803D7BB2D027Q44862147-85AD3B6C-629C-40A0-A9CB-6709783C2099Q45327156-38150672-4978-4B4D-AC2E-F329872B2149Q47653276-697371FD-21B4-4CF7-8E40-B0DC28AAC136Q47699498-0E35360E-6DAF-4FCE-B96D-3954DE5F40A3Q47908292-36B2BC1C-2336-4831-83BC-7AEE0F73F861Q51527887-5E7A1D49-C0F6-446B-B7E1-E44CF75F68C6Q57788718-4B824971-EDDB-412C-A99A-0A63EF174F96
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Myositis autoantibodies.
@en
type
label
Myositis autoantibodies.
@en
prefLabel
Myositis autoantibodies.
@en
P2860
P1476
Myositis autoantibodies.
@en
P2093
Andrew L Mammen
Livia Casciola-Rosen
P2860
P304
P356
10.1097/BOR.0B013E328358BD85
P577
2012-11-01T00:00:00Z